US › Healthcare

CONMED Corporation (CNMD)

US · Healthcare · Medical Devices

$50.40-2.82%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$343.5M

Revenue YoY

+0.1%

Net profit

$23.1M

Profit YoY

+7.7%

EPS

$1.38

EPS estimate

$1.10

Net margin

6.7%

EPS came in at 1.38 against a street estimate of 1.10 — a beat of 25.5%.

Key statistics

Market cap

$1.39B

P/E

25.0

Forward P/E

27.2

P/B

1.33

Book value

$34.73

EPS (TTM)

$1.85

Dividend yield

0.43%

52-week high

$56.43

52-week low

$31.44

50-day MA

$37.42

200-day MA

$39.91

Beta

0.93

Analyst view

Analysts rate CONMED Corporation a hold (0 buy, 6 hold, 0 sell out of 6) with an average price target of $45.50.

Shareholding

Insiders

0.43%

Institutions

116.19%

Largest institutional holders

Fund	Stake
BlackRock Inc	16.11%
Earnest Partners LLC	8.58%
Vanguard Portfolio Management, LLC	6.93%
Fuller & Thaler Asset Management Inc	5.48%
Bank of America Corp	4.68%
Dimensional Fund Advisors, Inc.	4.65%
Vanguard Capital Management, LLC	4.62%
State Street Corp	4.62%

Recent filings & reports

Document	Date
Quarterly report · Q2 2026	2026-07-29
Results announced · Q3 2026	2026-07-29
Board / officer change · Q2 2026	2026-06-17
Material agreement · Q2 2026	2026-06-04
Material agreement · Q2 2026	2026-06-01
Quarterly report · Q1 2026	2026-04-30
Proxy statement · Q2 2026	2026-04-07
Annual report FY2025	2026-02-17

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for CONMED Corporation — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.